HCA Holdings, Inc. (NYSE:HCA) Stock Rating Lowered by Zacks Investment Research
HCA Holdings, Inc. (NYSE:HCA) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Friday, July 14th.
According to Zacks, “HCA Healthcare's shares have gained 10% in the past one year, outpacing the Zacks categorized Medical Hospital industry that declined by 0.2%. Its top line has been growing over the past several quarters due to robust volumes, improved payor and service mix, and effective cost management. Its numerous acquisitions over the past many years have helped it gain a strong foothold in the industry. Its solid balance sheet, characterized by consistent generation of cash flows that are used for investment activities, is another positive. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at $1.80 reflecting nearly 8.6% year over year growth. However, the company’s bad debts are likely to drain its bottom line. Also its commercial business remains under pressure. Regulatory uncertainty with respect to the repeal and replace of the Obamacare is other concern.”
Several other equities research analysts have also commented on HCA. Mizuho upgraded shares of HCA Holdings from a “neutral” rating to a “buy” rating and set a $98.00 price objective for the company in a research note on Monday, March 27th. Deutsche Bank AG initiated coverage on shares of HCA Holdings in a research note on Tuesday, April 4th. They set a “buy” rating and a $103.00 price target for the company. Cantor Fitzgerald restated a “buy” rating and set a $95.00 price target on shares of HCA Holdings in a research note on Monday, April 17th. Morgan Stanley initiated coverage on shares of HCA Holdings in a research note on Tuesday, June 6th. They set an “equal weight” rating and a $90.00 price target for the company. Finally, Leerink Swann upgraded shares of HCA Holdings from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $92.00 to $100.00 in a research note on Tuesday, June 6th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and twelve have issued a buy rating to the company’s stock. HCA Holdings has a consensus rating of “Buy” and an average target price of $93.50.
HCA Holdings (HCA) traded down 0.46% during mid-day trading on Friday, hitting $78.13. The company had a trading volume of 3,036,394 shares. The company’s 50 day moving average price is $84.43 and its 200-day moving average price is $84.38. HCA Holdings has a 12-month low of $67.00 and a 12-month high of $91.03. The firm has a market capitalization of $29.33 billion, a PE ratio of 10.47 and a beta of 0.67.
HCA Holdings (NYSE:HCA) last posted its quarterly earnings data on Tuesday, July 25th. The company reported $1.75 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.80 by $0.05. The firm had revenue of $10.73 billion during the quarter, compared to analysts’ expectations of $10.76 billion. HCA Holdings had a net margin of 6.64% and a negative return on equity of 48.08%. The company’s quarterly revenue was up 4.0% on a year-over-year basis. During the same quarter last year, the business posted $1.66 EPS. On average, analysts forecast that HCA Holdings will post $7.20 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: “HCA Holdings, Inc. (NYSE:HCA) Stock Rating Lowered by Zacks Investment Research” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/08/hca-holdings-inc-nysehca-stock-rating-lowered-by-zacks-investment-research-updated-updated-updated.html.
In other HCA Holdings news, SVP Jana Joustra Davis sold 8,302 shares of the firm’s stock in a transaction on Thursday, May 11th. The shares were sold at an average price of $85.02, for a total value of $705,836.04. Following the completion of the transaction, the senior vice president now directly owns 36,589 shares of the company’s stock, valued at approximately $3,110,796.78. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Sandra L. Morgan sold 5,915 shares of the firm’s stock in a transaction on Wednesday, May 17th. The shares were sold at an average price of $82.74, for a total transaction of $489,407.10. Following the completion of the transaction, the senior vice president now directly owns 2,420 shares of the company’s stock, valued at $200,230.80. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 151,424 shares of company stock valued at $12,787,290. 2.90% of the stock is owned by insiders.
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Lee Financial Co bought a new position in shares of HCA Holdings during the second quarter worth about $125,000. IFP Advisors Inc boosted its position in shares of HCA Holdings by 9.4% in the first quarter. IFP Advisors Inc now owns 1,605 shares of the company’s stock worth $143,000 after buying an additional 138 shares during the last quarter. Global X Management Co. LLC boosted its position in shares of HCA Holdings by 29.9% in the first quarter. Global X Management Co. LLC now owns 2,162 shares of the company’s stock worth $192,000 after buying an additional 498 shares during the last quarter. Peak Asset Management LLC bought a new position in shares of HCA Holdings during the first quarter worth about $201,000. Finally, Ifrah Financial Services Inc. bought a new position in shares of HCA Holdings during the first quarter worth about $210,000. 74.54% of the stock is owned by hedge funds and other institutional investors.
About HCA Holdings
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Stock Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related stocks with our FREE daily email newsletter.